The DNAM-1 receptor/ligand axis is altered in patients with AML with both downregulation of DNAM-1 receptors on NK cells and low expression of DNAM-1 ligands (CD112/155) on AML clones leading to poor NK cell conjugation and killing [88, 89]. This evidence concerns the gene CD226 and acute myeloid leukemia.